Sergio
Vázquez Estévez

Foto de Sergio

Foto de Instituto Valenciano de Oncologia

Instituto Valenciano de Oncologia

Valencia, España

Publicacións en colaboración con investigadores/as de Instituto Valenciano de Oncologia (6)

2024

Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study
Clinical and Translational Oncology
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
Cancers, Vol. 16, Núm. 14

2023

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide
Prostate, Vol. 83, Núm. 4, pp. 376-384

2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study
Annals of Oncology, Vol. 28, Núm. 7, pp. 1-9

2016

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1

2014

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma
Cancer Chemotherapy and Pharmacology, Vol. 73, Núm. 6, pp. 1095-1107

Proxecto CRIS desenvolto en colaboración coa Fundación Dialnet (Universidad de La Rioja)